Genomix Co. raises 1 billion Yen by 3d party allotment

The company is engaged in R&D that promotes healing and regeneration of injured tissue by activating bone marrow-derived stem cells and accumulating them in the affected area via circulation of peripheral blood.

https://genomix.co.jp